Bcal Diagnostics Ltd Capital Reinvestment Ratio

Latest as of December 2020: 0.00x

Bcal Diagnostics Ltd capital reinvestment ratio. Bcal Diagnostics Ltd (BDX) has a Capital Reinvestment Ratio of 0.00x as of December 2020, meaning it reinvests 0% of its operating cash flow (AU$118.98K) in capital expenditures (AU$5.00). Check Bcal Diagnostics Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

AU$118.98K

AUD

Capital Expenditures

AU$5.00

AUD

Data as of

Dec 2020

Most recent filing

Bcal Diagnostics Ltd Capital Reinvestment Ratio by Year (None–None)

Bcal Diagnostics Ltd capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Bcal Diagnostics Ltd (BDX) cash flow conversion.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow